SLC5A2 and diabetes mellitus: Keywords such as “T2DM,” "Type 2 Diabetes Mellitus," “SGLT2i,” "Sodium-glucose cotransporter-2 inhibitors," “DPP-4 inhibitors,” “Biguanides,” “Metformin,” and “GLP-1 RA” were utilized to identify recent and relevant findings.